Donald A Bergstrom

CIK 1709772 · President, R&D · last filed 2026-01-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.26M

Companies

3

Total Filings

61

Lifetime Open-Market Net

-$10.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RLAY President, R&D 422,733 $14.81 $6.26M -$10.16M 55 2026-01-29
Fusion Pharmaceuticals Inc. (FUSN) Delisted Director $21.55 $0 5 2024-06-04
Mersana Therapeutics, Inc. (MRSN) Delisted Chief Medical Officer $29.08 $0 1 2018-02-06

Recent Filings · Page 3 of 7

61 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-09-29 RLAY Mixed +580 $7.7K EDGAR
2023-07-31 RLAY Sell (S) −2,683 -$31.7K EDGAR
2023-06-28 RLAY Sell (S) −647 -$7.8K EDGAR
2023-06-14 Fusion Pharmaceuticals Inc. (FUSN) Delisted Grant (A) $0 EDGAR
2023-06-01 RLAY Sell (S) −2,850 -$31.8K EDGAR
2023-05-01 RLAY Sell (S) −1,383 -$15.4K EDGAR
2023-03-28 RLAY Sell (S) −763 -$11.7K EDGAR
2023-01-31 RLAY Sell (S) −1,429 -$30.8K EDGAR
2023-01-19 RLAY Grant (A) +160,390 $0 EDGAR
2022-12-28 RLAY Sell (S) −980 -$14.2K EDGAR
Showing 2130 of 61
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.